Rimegepant

證據等級: L5

預測適應症: 6 個

RIMEGEPANT: Repurposing Evaluation — Insufficient Data to Complete Assessment

Summary

RIMEGEPANT (DrugBank: DB12457) is a small-molecule drug queried through the TxGNN repurposing pipeline on 2026-03-29. The current Evidence Pack contains no TxGNN predicted indications, no confirmed original indication, and no mechanism of action data. A full repurposing evaluation cannot be completed at this stage; this report documents the current data state and defines the minimum requirements to proceed.

Quick Overview

Item	Content
Original Indication	Not available in current Evidence Pack
Predicted New Indication	No predictions returned
TxGNN Prediction Score	N/A
Evidence Level	N/A — No predictions to evaluate
Taiwan Market Status	✗ Not marketed
Number of Authorizations	0
Recommended Decision	Hold — Critical data missing

Taiwan Market Information

RIMEGEPANT currently has no drug licenses registered in Taiwan. There are no approved products, dosage forms, or indications on record with the TFDA as of the data cutoff (2026-04-20).

Safety Considerations

Please refer to the package insert for safety information.

Conclusion and Next Steps

Decision: Hold

Rationale: The Evidence Pack returned zero TxGNN predictions and is missing both original indication data and mechanism of action information, making it impossible to assess repurposing rationale, evidence strength, or safety relevance at this time.

To proceed, the following is needed:

TxGNN predictions — Re-run the TxGNN pipeline for DB12457 and confirm that predicted_indications is populated before generating a full report
Original indication — Retrieve approved indication(s) from DrugBank or the FDA/EMA label (RIMEGEPANT is commercially available outside Taiwan under brand names including Nurtec ODT and Vydura)
Mechanism of action — Query DrugBank API for MOA; RIMEGEPANT is a CGRP receptor antagonist — this should be confirmable from the public DrugBank record
Safety data — Download and parse the TFDA package insert PDF to extract key warnings and contraindications (Data Gap DG001, severity: Blocking)
DDI profile — Re-query the DDI database; the current query returned not_found, which may reflect a data source gap rather than an absence of interactions
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.